-
42m 25s
-
1h 2sPart 2 | Session 7 Session 2.3: Left Main & Bifurcations
-
1h 1m 6sPart 2 | Session 8 Session 2.4: Live Cases and Discussion
-
1m 38sPart 2 | Session 9 Day Close
-
2m 49sPart 3 | Session 1 Day Welcome: Debates & Controversies
-
59m 8sPart 3 | Session 2 Session 3.1: Keynote & Debate
-
1h 1m 40sPart 3 | Session 3 Session 3.2: Live Cases and Discussion
-
46m 15s
-
54m 54sPart 3 | Session 5 Session 3.3: Debates
-
3m 4sPart 3 | Session 6 Day Close
-
3m 4sPart 1 | Session 1 Day Welcome: Structural Heart Disease
-
58m 10sPart 1 | Session 2 Session 1.1: Atrioventricular Valve Replacement Beyond TEER?
-
1h 5m 20sPart 1 | Session 3 Session 1.2: Live Cases and Discussions
-
1h 8sPart 1 | Session 6 Session 1.3: Key Issues in TAVI
-
1h 2m 15sPart 1 | Session 7 Session 1.4: Live Cases and Discussions
-
1m 21sPart 1 | Session 8 Day Close
-
2m 52sPart 2 | Session 2 Day Welcome: Complex PCI
-
1h 3mPart 2 | Session 3 Session 2.1: Balloon Revolution
-
54m 58sPart 2 | Session 4 Session 2.2: Live Cases and Discussions
Welcome to the on-demand sessions of Transcatheter Interventions Online 2023, broadcast live on 15-17 March 2023. If you missed the live broadcast, here you can access all sessions in full.
TIO 2023 brought together a leading international faculty to create a rich, interactive experience to support the global interventional cardiology community stay abreast of the latest developments in transcatheter treatment strategies. Combining expert opinion and discussion, presentations and live cases from centres of excellence from both sides of the Atlantic, TIO 2023 again delivered best-in-class learning, supporting the latest in diagnosis, treatment strategies and patient management.
The live version of Transcatheter Interventions Online 2023 was CME-accredited. This on-demand version is not.
A CME-accredited version of each session of TIO 2023 is now available on Radcliffe Medical Education.
Key Learning Objectives
- Compare the utility of repair and replacement valve technology in mitral regurgitation
- Individualise valve choice for aortic regurgitation based on valve durability and patient features
- Recall the utility and limitations of specialty balloons
- Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
- Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
- Identify suitable patients for interatrial shunting
- Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
Target Audience
- Interventional Cardiologists
- Surgeons with an interest in transcatheter treatment strategies for coronary and structural heart disease
- Interventional Cardiology Nurses
More from this programme
Part 1
Day One: Structural Heart Disease
Part 2
Day Two: Complex PCI
Part 3
Day Three: Debates and Controversies
Faculty Biographies
David Hildick-Smith
Prof David Hildick-Smith is Professor of Interventional Cardiology and Consultant Cardiologist at the Sussex Cardiac Centre - the Regional Specialist Unit. He is Director of the Cardiac Research, ex-Treasurer of the British Cardiovascular Interventions Society, and, with more than 20 years experience of Interventional Cardiology, is considered one of the country's leading experts in management of Cardiovascular complaints.
A pioneer of Interventional Cardiology, David is recognised internationally as a leader in cardiovascular diagnosis and treatment.
Giuseppe Tarantini
Prof Giuseppe Tarantini is the Head of the Interventional Cardiology Unit within the Department of Cardiac, Thoracic, and Vascular Sciences at the University of Padua Medical School, Padua, IT. He is a globally recognised researcher specialising in ischemic heart disease, structural heart disease, and cardiomyopathies.
Prof Tarantini serves as the primary operator for a diverse array of interventional procedures, encompassing coronary interventions (including atherectomies), peripheral interventions (such as carotid and renal procedures), and structural heart interventions (involving ASDs, PFOs, TAVI, and AVP).
In addition to his clinical work, Prof Tarantini is a distinguished faculty member at various international conferences, including Transcatheter Cardiovascular Therapeutics (TCT), the Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR, and the European Society of Cardiology (ESC). He boasts a publication record of 245 clinical…
Lars Søndergaard
Professor Lars Søndergaard is a consultant cardiologist at Rigshospitalet – Copenhagen, Denmark. Professor of Cardiology at University of Copenhagen, he published over 300 peer reviewed articles, and more than 15 textbook chapters. His research interests are focused on adults with congenital heart diseases and catheter-based heart valve interventions, as well as congenital and structural heart diseases. He led the first-in-human transcatheter mitral valve implantation (CardiAQ) in 2012 and he actively participated to several trials, including NOTION (transcatheter vs. surgical aortic valve replacement in patients with aortic stenosis and low surgical risk), and the REDUCE randomised trial (PFO vs anti-platelet therapy after cryptogenic stroke).
Stefan Toggweiler
Stefan Toggweiler, PD Dr med, is the head of interventional valve therapy at Heart Center Lucerne.